QA: Sio Gene Therapies Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001636050_2022_Sio_Gene_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001636050, Sio Gene Therapies Inc

  xvar xval
0 AssetsCurrent 132,333,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 478,000
3 remainder_Assets 2,336,000
4 LiabilitiesCurrent 10,848,000
5 LiabilitiesNoncurrent 932,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,103,835
9 ResearchAndDevelopmentExpense -565,666
10 remainder_Expenses 106,309
11 remainder_Revenues 0
12 remainder_NetIncome 1,378,880
13 remainder_ComprehensiveNetIncome -964,557
  yvar yval
0 Assets 135,147,000
1 Liabilities 11,780,000
2 Expenses 17,644,478
3 Revenues 0
4 StockholdersEquity 123,367,000
5 NetIncome -16,265,598
6 ComprehensiveNetIncome -16,747,876
7 BaseVar 83,457,458
8 EconomicCapitalRatiobeforeLimitedLiability 3.43
9 EconomicCapitalRatio 3.98

Edgar->Model Mapping

Feature Distribution

Change over Time